Clinical Trial Update: Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) [Phase 2]

View source ↗

Summary

Phase 2 trial of extended-release naltrexone for methamphetamine dependence in men who have sex with men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: San Francisco Department of Public Health | Conditions: Amphetamine-Related Disorders | Phase 2 | Status: COMPLETED